Predictive factors of efficacy of Nalfurafine hydrochloride for pruritus in patients with PBC
Phase 4
- Conditions
- primary biliary cholangitis
- Registration Number
- JPRN-UMIN000021681
- Lead Sponsor
- Iwate Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with pregnancy, patients with malignancy, patients with a history of allergy to nalfurafine, patients with severe liver impairment (Child-Pugh grade C), and patients who were not indicated for nalfurafine treatment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of pruritus at 8 weeks after nalfurafine administration.
- Secondary Outcome Measures
Name Time Method blood biochemistry, serum autaxin levels